VeriMomБезопасен ли cocamidopropyl pg-dimonium chloride phosphate при беременности?
No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
Pregnancy-safe products containing cocamidopropyl pg-dimonium chloride phosphate
Related ingredients
Frequently asked questions
- Безопасен ли cocamidopropyl pg-dimonium chloride phosphate при беременности?
- No harmonised CLP reproductive classification (no H360/H361) is documented for this ingredient in ECHA Annex VI, and there are no SCCS or CIR safety opinions identifying reproductive hazard. No peer‑reviewed reproductive or developmental toxicity data specifically implicating this ingredient were identified in the literature. Dermal cosmetic use implies low but measurable exposure rather than negligible (typical for topically applied surfactants/quaternary salts). Sources consulted: ECHA C&L/Annex VI (no harmonised classification), PubMed (no reproductive/developmental studies found), PubChem/CosIng/EWG (no reproductive flags).
- Безопасен ли cocamidopropyl pg-dimonium chloride phosphate при грудном вскармливании?
- Same rationale as pregnancy: no evidence of reproductive or lactation-specific toxicity in authoritative sources, and no mechanistic data indicating mammary transfer. Topical use implies low but measurable exposure; therefore breastfeeding exposure considered low.
- Безопасен ли cocamidopropyl pg-dimonium chloride phosphate для кожи малыша?
- No infant‑specific hazard data identified. Because infant skin (0–3 yr) has a higher surface‑area‑to‑weight ratio and a less mature barrier, exposure score is increased by +1 versus adult (low → moderate). No evidence was found that infant exposure leads to systemic reproductive/mechanistic effects.
- Как VeriMom оценивает cocamidopropyl pg-dimonium chloride phosphate?
- VeriMom оценивает cocamidopropyl pg-dimonium chloride phosphate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы cocamidopropyl pg-dimonium chloride phosphate при беременности?
- См. наш список безопасных альтернатив cocamidopropyl pg-dimonium chloride phosphate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.